The present and future of prostatitis

Korean Journal of Urology

Volumn 49, Issue 6, 2008, Pages 475-489

  Cho, In Rae ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Chronic pelvic pain syndrome; Etiology; Neurogenic inflammation; Prostatitis; Treatment

Indexed keywords

ALFUZOSIN; ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOGLYCOSIDE DERIVATIVE; AMITRIPTYLINE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BIFLAVONOID; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; COLCHICINE; COTRIMOXAZOLE; CYCLOSPORIN A; DOXAZOSIN; FINASTERIDE; FLEROXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MESSENGER RNA; PENTOSAN POLYSULFATE; PROSTATE SPECIFIC ANTIGEN; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TAMSULOSIN; TERAZOSIN; TETRACYCLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANTIMICROBIAL THERAPY; AUTOIMMUNE DISEASE; CHLAMYDIA TRACHOMATIS; CHRONIC DISEASE; CHRONIC PROSTATITIS; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CORYNEBACTERIUM; DISEASE CLASSIFICATION; ECHOGRAPHY; EMPIRICISM; ENDOCRINE DISEASE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; INFECTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; KLEBSIELLA; MALE; MICROWAVE THERAPY; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; NEUROGENIC INFLAMMATION; NEUROLOGIC DISEASE; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; PELVIS PAIN SYNDROME; PHYSIOTHERAPY; PHYTOTHERAPY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROSTATITIS; PROTEUS; PSEUDOMONAS AERUGINOSA; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SERRATIA; STAPHYLOCOCCUS; TRANSURETHRAL NEEDLE ABLATION; TREATMENT RESPONSE; UREAPLASMA UREALYTICUM;

EID: 47249146388     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2008.49.6.475     Document Type: Review

References (99)

1. Woo YN. Prostatitis. Korean J Urol 1994;35:575-85
2. Cho IR. Evaluation and treatment of patients with prostatitis. Korean J Androl 2005;23:1-114
3. Fall M, Baranowski AP, Fowler CJ, Lepinard V, Malone-Lee JG, Messelink EJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol 2004;46:681-9
4. Wenninger K, Heiman JR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996;155:965-8
5. Stamey TA. Urinary tract infections in male. In: Stamey TA, editor. Pathogenesis and treatment of urinary tract infections. 1st ed. Baltimore: Williams & Wilkins; 1980;342-429
6. Nickel JC. Prostatitis: myths and realities. Urology 1998;51: 362-6
7. Nickel JC, Nigro M, Valiquette L, Anderson P, Patrick A, Mahoney J, et al. Diagnosis and treatment of prostatitis in Canada. Urology 1998;52:797-802
8. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968;5:492-518
9. Drach GW, Meares EM, Fair WR, Stamey TA. Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol 1978;120:266
10. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282:236-7
11. Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger RE. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urolology 1996;48:715-22
12. Goldstraw MA, Fitzpatrick JM, Kirby RS. What is the role of inflammation in the pathogenesis of prostate cancer? BJU Int 2007;99:966-8
13. Cho IR, Lee KC, Lee SE, Jeon JS, Park SS, Sung LH, et al. Clinical outcome of acute bacterial prostatitis, a multicenter study. Korean J Urol 2005;46:1034-9
14. Krieger JN, Riley DE. Prostatitis: what is the role of infection. Int J Antimicrob Agents 2002;19:475-9
15. Naber KG, Weidner W. Chronic prostatitis - an infectious disease? J Antimicrob Chemother 2000;46:157-61
16. Povlsen K, Bjornelius E, Lidbrink P, Lind I. Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis. Eur J Clin Microbiol Infect Dis 2002;21:97-101
17. Pontari MA. Chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am 2008;35:81-9
18. Pontari MA, Ruggieri MR. Mechanism in prostatitis/chronic pelvic pain syndrome. J Urol 2004;172:839-45
19. Hellstrom WJ, Schmidt RA, Lue TF, Tanagho EA. Neuromuscular dysfunction in nonbacterial prostatitis. Urology 1987;30: 183-8
20. Persson BE, Ronquist G. Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J Urol 1996;155: 958-60
21. Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S, et al. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol 2009;179:556-60
22. Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic syndrome. Urology 1998;52: 744-9
23. Berger RE, Miller JE, Rothman I, Krieger JN, Muller CH. Bladder petechiae after cystoscopy and hydrodistension in men daignosed with prostate pain. J Urol 1998;159:83-5
24. Nickel JC, Tripp DA, Chuai S, Litwin MS, McNaughton-Collins M, Landis JR, et al. Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int 2008;101:59-64
25. Naber KG, Bergman B, Bishop MC, Bierklund Johansen TE, Botto H, Lobel B, et al. Guidelines on urinary and male genital tract infections. In: EAU Healthcare Office, editor. Guidelines. 1st ed. Arnhem: EAU; 2001;49-56
26. Schaeffer AJ, National Institute of Diabetes and Digestive and Kidney Diseases of the US National Institutes of Health. NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis. Int J Antimicrob Agents 2004;24(Suppl 1):S49-52
27. Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted country study of urinary symptoms and health status among men. Urology 1998;51:578-84
28. Ku JH, Lee SH, Kim ME, Lee NK, Park YH, Seo YR. Relationship between chronic prostatitis and psychological problem. Korean J Urol 2001;42:521-7
29. Kim YS, Choi YD, Kang KH, Ryu RH, Choi HK, Park HS, et al. Study of prostatic disease and symptom between special occupation groups (taxi driver, barber). Korean J Urol 1998;39: 1093-7
30. Han MC, Kim JS, Shim BS. Analysis of the risk factors related to progression of chronic prostatitis. Korean J Urol 2005;46:1040-5
31. Bartoletti R, Cai T, Mondaini N, Dinelli N, Pinzi N, Pavone C, et al. Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study. J Urol 2007;178: 2411-5
32. Cho IR, Park SC, Park SS. The prevalence of the symptoms of the prostate syndrome patients under 50. Korean J Urol 1998;39:751-6
33. Lee JH, Jeon JS, Cho IR. Characteristic symptoms of chronic prostatitis/ chronic pelvic pain syndrome. Korean J Androl 2002;43:852-7
34. Yong DJ, Lee SO, Song HD, Oh BS, Cho SY, Jeon JS, et al. Prevalence of premature ejaculation in chronic pelvic pain syndrome. Korean J Androl 2007;25:21-5
35. Litwin MS, Collins MM, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA, et al. The national institutes of health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol 1999;162:369-75
36. Shoskes DA, Landis JR, Wang Y, Nickel JC, Zeitlin SI, Nadler R, et al. Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004;172:542-7
37. Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. Low agreement between previous physician diagnosed prostatitis and national institutes of health chronic prostatitis symptom index pain measures. J Urol 2004;171: 279-83
38. Nickel JC. Pre and post massage test (PPMT): a simple screen for prostatitis. Tech Urol 1997;3:38-43
39. Ludwig M, Schroeder-Printzen I, Ludecke G, Weidner W. Comparison of expressed prostatic secretions with urine after prostatic massage - a means to diagnose chronic prostatitis/inflammatory chronic pelvic pain syndrome. Urology 2000;55: 175-7
40. Hennenfent BR, Feliciano AE. Changes in white blood cell counts in men undergoing thrice-weekly prostatic massage, microbial diagnosis and antimicrobial therapy for genitourinary complaints. Br J Urol 1998;81:370-6
41. Muller CH, Berger RE, Mohr LE, Krieger JN. Comparison of microscopic methods for detecting inflammation in expressed prostatic secretions. J Urol 2001;166:2518-24
42. Krieger JN, Jacobs R, Ross SO. Detecting urethral and prostatic inflammation in patients with chronic prostatitis. Urology 2000;55:186-92
43. McNaughton Collins M, Fowler FJ Jr, Elliott DB, Albertsen PC, Barry MJ. Diagnosis and treating chronic prostatitis: Do urologists use the four-glass test? Urology 2000;55:403-7
44. Jang JH, Kim SJ. Anaerobic bacterial isolation in patients with chronic prostatitis syndrome. Korean J Urol 1994;35:640-5
45. Berger RE, Krieger JN, Rothman I, Muller CH, Hillier SL. Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol 1997;157:863-5
46. Krieger JN, Riley DE, Roberts MC, Berger RE. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 1996;34:3120-8
47. Krieger JN, Riley DE. Bacteria in the chronic prostatitis-chronic pelvic pain syndrome: molecular approaches to critical research questions. J Urol 2002;167:2574-83
48. Lee SJ, Cho YH, Kim CS, Shim BS, Cho IR, Chung JI, et al. Screening for Chlamydia and Gonorrhea by strand displacement amplification in homeless adolescents attending youth shelters in Korea. J Korean Med Sci 2004;19:495-500
49. Ward BB. How many species of prokaryotes are there? Proc Natl Acad Sci USA 2002;99:10234-6
50. Park SC, Cho IR, Park SS. What are the characteristic transrectal ultrasonographic findings in chronic prostatitis? Korean J Urol 1998;39:530-6
51. Patel U, Rickards D. The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correction. Br J Urol 1994;74:590-5
52. Cho IR, Keener TS, Nghiem HV, Winter T, Krieger JN. Prostate blood flow characteristics in the chronic prostatitis/pelvic pain syndrome. J Urol 2000;163:1130-3
53. Kaplan SA, Santarosa RP, D'Alisera PM, Fay BJ, Ikeguchi EF, Hendricks J, et al. Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 1997;157:2234-7
54. Lee CU, Seong BM. Urodynamic findings of chronic non-bacterial prostatitis patients with urinary symptoms. Korean J Urol 2006;47:268-71
55. Kim TC, Park KH, Kim YK, Lee HS. Endoscopic evaluation ninty-one cases of chronic prostatitis. Korean J Urol 1962;3:51-8
56. Cho IR, Kim GJ. Chronic prostatitis and urethritis. Korean J Androl 1999;17:33-7
57. Zaichick VY, Sviridova TV, Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int Urol Nephrol 1996;28:687-94
58. Nickel JC, Ardern D, Downey J. Cytologic evaluation of urine is important in evaluation of chronic prostatitis. Urology 2002;60:225-7
59. Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology 2002;60:78-83
60. Roberts RO, Bergstralh EJ, Bass SE, Lieber MM, Jacobsen SJ. Prostatitis as a risk factor for prostate cancer. Epidemiology 2004;15:93-9
61. Cho IR, Kim GJ, Park SS, Choi HS. PSA and prostatitis in men under 45 years old. Korean J Urol 1998;39:633-7
62. Cho IR, Chang YS, Roh JS, Jeon JS, Park SS. Change of PSA and PSAD after antibiotic treatment in patients with prostatitis. Korean J Androl 2002;20:100-5
63. Lee SO, Cho IR, Lee KC, Kim HS. Evaluation of serum prostate specific antigen in subclinical prostatitis: the role of pathology of inflammation. Korean J Urol 2006;47:31-6
64. Bozeman CB, Carver BS, Eastham JA, Venable DD. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 2002;167:1723-6
65. Potts JM. Prospective identification of NIH Category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000;164:1550-3
66. Letran JL, Brawer MK. Prostate specific antigen and prostatitis. In: Nicket JC, editor. Textbook of prostatitis. 1st ed. Oxford: Isis Medical Media; 1999;241-4
67. Dimitrakov JD, Kaplan SA, Kroenke K, Jackson JL, Freeman MR. Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach. Urology 2006;67: 881-8
68. Benway BM, Moon TD. Bacterial prostatitis. Urol Clin North Am 2008;35:23-32
69. Naber KG, Adam D. Classification of fluoroquinolones. Int J Antimicrobial Agents 1998;10:255-7
70. Bjerklund Johansen TE, Gruneberg RN, Guibert J, Hofstetter A, Lobel B, Naber KG, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998;34:457-66
71. Cho IR. Chronic prostatitis/chronic pelvic pain syndrome: guidelines for antibiotic therapy. Korean J UTII 2006;1:39-44
72. Lee SD, Lee SJ, Hwang TK, Yoon DK, Lee KS, Sung LH, et al. Multicenter clinical outcome of gatifloxacin for chronic prostatitis (NIH category II or IIIa) in Korea. Korean J UTII 2007;2:53-60
73. Baert L, De Ridder D. In loco antibiotics in chronic bacterial prostatitis. In: Weider W, Madsen PO, Schiefer HG, editors. Prostatitis. 1st ed. Berlin: Springer-Verlag; 1994;191-6
74. Kim YJ, Ryu JK, Lee HJ, Choi WS, Suh JK. Comparison of the efficacy of transperineal intraprostatic injection and oral administration of fluoroquinolone in men with chronic bacterial prostatitis-seminal vesiculitis. Korean J Urol 2006;47: 1185-90
75. Kim TH, Kim TH, Kim HR, Lee MK, Myung SC, Kim YS. Detection of cryptic microorganisms in patients with chronic prostatitis by multiplex polymerase chain reaction. Korean J Urol 2007;48:304-9
76. Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003;62:614-7
77. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/ chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004;141:581-9
78. Jung YH, Kim JG, Cho IR. The efficacy of terazosin in the management of chronic pelvic pain syndrome (CPPS): comparison between category IIIa. and IIIb. Korean J Urol 2006;47: 1191-6
79. Gul O, Eroglu M, Ozok U. Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Int Urol Nephrol 2001;32:433-6
80. Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/ chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004;171:1594-7
81. Mehik A, Alas P, Nickel JC, Sarpola A, Helstrom PJ. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003;62:425-9
82. Barbalias GA, Nikiforidis G, Liatsikos EN. α-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998;159:883-7
83. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, et al. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology 2004;64:881-6
84. Geppetti P, Nassini R, Materazzi S, Benemei S. The concept of neurogenic inflammation. BJU Int 2008;101(Suppl 3):2-6
85. Trevisani M, Campi B, Gatti R, Andre E, Materazzi S, Nicoletti P, et al. The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract. Eur Urol 2007;52:901-8
86. Shoskes DA, Zeitlin SI, Shahed A, Raifer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999;54:960-3
87. Zermann D, Ishigooka M, Schubert J, Schmidt RA. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 2000;38:393-9
88. Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004;93:991-5
89. Persson BE, Ronquist G, Ekblom M. Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study. J Urol 1996;155:961-4
90. Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 2005;173:1252-5
91. Shim BS. Complementary and alternative therapy for chronic prostatitis/ chronic pelvic pain syndrome. Korean J UTII 2007; 2:143-50
92. Cornel EB, van Haarst EP, Schaarsberg RW, Geels J. The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Eur Urol 2005;47:607-11
93. Yang SK, Sung WS, Chung H, Kim TW, Kim HS, Lho YS. Biofeedback and functional electrical stimulation therapy for patients with intractable chronic pelvic pain syndrome. Korean J Urol 2003;44:1220-4
94. Lee KC, Choi H, Park HS, Kim JJ, Moon DG. Therapeutic efficacy of extracorporeal magnetic therapy in chronic pelvic pain syndrome. Korean J Urol 2003;44:693-6
95. Kim SW, Kim SH, Lee CH, Lee SJ, Cho YH, Yoon MS. Clinical efficacy of extracorporeal magnetic innervation for chronic pelvic pain syndrome. Korean J Androl 2003;21:44-7
96. Yavascaoglu I, Oktay B, Simşek U, Ozyurt M. Role of ejaculation in the treatment of chronic non-bacterial prostatitis. Int J Urol 1999;6:130-4
97. Kastner C, Hochreiter W, Huidobro C, Cabezas J, Miller P. Cooled transurethral microwave thermotherapy for intractable chronic prostatitis - results of a pilot study after 1 year. Urology 2004;64:1149-54
98. Leskinen MJ, Kilponen A, Lukkarinen O, Tammela TL. Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology 2002;60:300-4
99. Desireddi NV, Campbell PL, Stern JA, Sobkoviak R, Chuai S, Shahrara S, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-Iα as possible biomarkers for the chronic pelvic pain syndrome. J Urol 2008;179:1857-62